☆ 4.7 Review

β2-adrenoceptor agonists: current and future direction

BRITISH JOURNAL OF PHARMACOLOGY (2011)

Get Full Text
Add to Collection

Journal

BRITISH JOURNAL OF PHARMACOLOGY
Volume 163, Issue 1, Pages 4-17

Publisher

WILEY
DOI: 10.1111/j.1476-5381.2011.01216.x

Keywords

Asthma; COPD; bronchodilators; beta(2)-adrenoceptor agonists; long-acting beta(2)-adrenoceptor agonists; ultra long-acting beta(2)-adrenoceptor agonists; intravenous beta(2)-adrenoceptor agonists

Categories

Pharmacology & Pharmacy

Funding

  1. Abbott
  2. AstraZeneca
  3. Boehringer Ingelheim
  4. Chiesi Farmaceutici
  5. Dey
  6. GSK
  7. Menarini Farmaceutici
  8. Mundipharma
  9. Novartis
  10. Nycomed
  11. Pfizer
  12. Sanovel
  13. Sigma Tau
  14. Valeas

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.